Bérengère Rozier Aubry

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


110 publications

2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
2022
 
Small fiber neuropathy in hypermobile Ehlers Danlos syndrome/hypermobility spectrum disorder.
Fernandez A., Aubry-Rozier B., Vautey M., Berna C., Suter M.R., 2022/12. Journal of internal medicine, 292 (6) pp. 957-960. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_901E70610EEA]
2020
Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.
Camponovo C., Aubry-Rozier B., Lamy O., Gonzalez Rodriguez E., 2020/12. Osteoporosis international, 31 (12) pp. 2485-2491. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A58AE6208B2F]
Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years.
Möller B., Aletaha D., Andor M., Atkinson A., Aubry-Rozier B., Brulhart L., Dan D., Finckh A., Grobéty V., Mandl P. et al., 2020/07/01. Rheumatology, 59 (7) pp. 1556-1565. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_637740FA2B17]
“Inflammaging” and bone in the OsteoLaus cohort
Fischer Jessica, Hans Didier, Lamy Olivier, Marques-Vidal Pedro, Vollenweider Peter, Aubry-Rozier Bérengère, 2020/03. Immunity & Ageing, 17 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_526576B40374]
 
OsteoLaus: raisons d’être et premiers résultats []
Shevroja E., Hans D., Aubry-Rozier B., Gonzalez-Rodriguez E., Lamy O., 2020/01. Praxis, 109 (1) pp. 19-22. Peer-reviewed.
[DOI][Pmid][serval:BIB_A26F733C6F9D]
 
Sixty spontaneous vertebral fractures after denosumab discontinuation in 15 women with early-stage breast cancer under aromatase inhibitors.
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Zaman K., Lamy O., 2020/01. Breast cancer research and treatment, 179 (1) pp. 153-159. Peer-reviewed.
[DOI][Pmid][serval:BIB_8D0CD026EA9F]
2019
 
Clinical Performance of the Updated Trabecular Bone Score (TBS) Algorithm, Which Accounts for the Soft Tissue Thickness: The OsteoLaus Study.
Shevroja E., Aubry-Rozier B., Hans G., Rodriguez E.G., Stoll D., Lamy O., Hans D., 2019/12. Journal of bone and mineral research, 34 (12) pp. 2229-2237. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F1454B86714A]
 
Bisphosphonates as a First-Line Treatment for Glucocorticoid-Induced Osteoporosis: Comment on the Article by Saag et al.
Gonzalez-Rodriguez E., Aubry-Rozier B., Stoll D., Lamy O., 2019/10. Arthritis & rheumatology, 71 (10) pp. 1770-1771. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F90DC7040A4D]
 
Cohort Profile: The OsteoLaus study.
Shevroja E., Marques-Vidal P., Aubry-Rozier B., Hans G., Rivadeneira F., Lamy O., Hans D., 2019/08/01. International journal of epidemiology, 48 (4) pp. 1046-1047g. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0588F97D36AC]
 
Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.
Lamy O., Fernández-Fernández E., Monjo-Henry I., Stoll D., Aubry-Rozier B., Benavent-Núñez D., Aguado P., Gonzalez-Rodriguez E., 2019/05. Osteoporosis international, 30 (5) pp. 1111-1115. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0954776AB6A8]
 
Assessing bone impairment in ankylosing spondylitis (AS) using the trabecular bone score (TBS) and high-resolution peripheral quantitative computed tomography (HR-pQCT).
Caparbo V.F., Furlam P., Saad CGS, Alvarenga J.C., Aubry-Rozier B., Hans D., de Brum-Fernandes A.J., Pereira RMR, 2019/05. Bone, 122 pp. 8-13. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6A4AEAD16688]
 
Denosumab in early-stage breast cancer.
Gonzalez Rodriguez E., Aubry-Rozier B., Stoll D., Lamy O., 2019/05. The Lancet. Oncology, 20 (5) pp. e233. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B4AAE2D058A2]
 
Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.
Biver E., Calmy A., Aubry-Rozier B., Birkhäuser M., Bischoff-Ferrari H.A., Ferrari S., Frey D., Kressig R.W., Lamy O., Lippuner K. et al., 2019/05. Osteoporosis international, 30 (5) pp. 1125-1135. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8281472D9E9E]
 
Comment gérer l’effet rebond à l’arrêt du dénosumab et éviter les fractures vertébrales multiples ? [How to manage the rebound effect at denosumab discontinuation and avoid multiple vertebral fractures?]
Gonzalez Rodriguez E., Lamy O., Aubry-Rozier B., Stoll D., Uebelhart B., 2019/04/17. Revue medicale suisse, 15 (647) pp. 831-835. Peer-reviewed.
[Pmid][serval:BIB_C93F3BDC4548]
 
Que faire face à une fracture vertébrale ostéoporotique ? [What can we do at the discovery of an osteroporotic vertebral fracture ?]
Brulhart D., Stoll D., Gonzalez Rodriguez E., Aubry-Rozier B., 2019/04/17. Revue medicale suisse, 15 (647) pp. 815-820. Peer-reviewed.
[Pmid][serval:BIB_8A85B18DB383]
 
Hepatosplenomegaly, pneumopathy, bone changes and fronto-temporal dementia: Niemann-Pick type B and SQSTM1-associated Paget's disease in the same individual.
Voinea C., Gonzalez Rodriguez E., Beigelman-Aubry C., Leroy V., Aubry-Rozier B., Campos-Xavier B., Ballhausen D., Lazor R., Barbey F., Bonafé L. et al., 2019/03. Journal of bone and mineral metabolism, 37 (2) pp. 378-383. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_11FF7C377058]
 
Stopping Denosumab.
Lamy O., Stoll D., Aubry-Rozier B., Rodriguez E.G., 2019/02. Current osteoporosis reports, 17 (1) pp. 8-15. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E92DA5E8472]
2018
 
Fractures vertébrales multiples à l’arrêt du denosumab: comment les éviter? [Multiple Vertebral Fractures after Denosumab Discontinuation: How to Avoid Them?]
Lamy O., Gonzalez Rodriguez E., Stoll D., Aubry-Rozier B., Livio F., 2018/06. Praxis, 107 (12) pp. 649-654. Peer-reviewed.
[DOI][Pmid][serval:BIB_AFA207F97FE4]
Impact of a fracture liaison service on patient management after an osteoporotic fracture: the CHUV FLS.
Aubry-Rozier B., Stoll D., Gonzalez Rodriguez E., Hans D., Prudent V., Seuret A., Farron A., Lamy O., 2018. Swiss medical weekly, 148 pp. w14579. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_79179583CDD7]
2017
 
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women.
Lamy O., Aubry-Rozier B., Gonzalez-Rodriguez E., 2017/12/19. Annals of internal medicine, 167 (12) pp. 900-901. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9FB48D33B7D5]
 
Maladies vasculaires rares, mise en place d’un centre multidisciplinaire spécialisé au CHUV [Rare vascular diseases, building dedicated multidisciplinary specialized center]
Krieger C., Baud D., Bouchardy J., Christen-Zaech S., De Buys A., Deglise S., El Ezzi O., Fresa M., Hofer M., Hohl D. et al., 2017/12/06. Revue medicale suisse, 13 (586) pp. 2109-2115. Peer-reviewed.
[Pmid][serval:BIB_87537126CDFD]
 
Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.
Tsourdi E., Langdahl B., Cohen-Solal M., Aubry-Rozier B., Eriksen E.F., Guañabens N., Obermayer-Pietsch B., Ralston S.H., Eastell R., Zillikens M.C., 2017/12. Bone, 105 pp. 11-17. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_070363935C4C]
 
Administration de fer, hypophosphatémie et ostéomalacie []
Aubry-Rozier B., Stoll D., Rodriguez Gonzalez E., 2017/09/27. Revue medicale suisse, 13 (576) p. 1665. Peer-reviewed.
[Pmid][serval:BIB_E627FE5837A9]
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCO.
Meier C., Uebelhart B., Aubry-Rozier B., Birkhäuser M., Bischoff-Ferrari H.A., Frey D., Kressig R.W., Lamy O., Lippuner K., Stute P. et al., 2017/09/05. Swiss medical weekly, 147 pp. w14484. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2F7530178F85]
 
High Evening Cortisol Level Is Associated With Low TBS and Increased Prevalent Vertebral Fractures: OsteoLaus Study.
Gonzalez Rodriguez E., Lamy O., Stoll D., Metzger M., Preisig M., Kuehner C., Vollenweider P., Marques-Vidal P., Waeber G., Aubry-Rozier B. et al., 2017/07/01. The Journal of clinical endocrinology and metabolism, 102 (7) pp. 2628-2636. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA0158609A94]
 
Impact of lumbar syndesmophyte on bone health as assessed by bone density (BMD) and bone texture (TBS) in men with axial spondyloarthritis.
Wildberger L., Boyadzhieva V., Hans D., Stoilov N., Rashkov R., Aubry-Rozier B., 2017/07. Joint, bone, spine, 84 (4) pp. 463-466. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_695D49A0EBF0]
 
Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases.
Anastasilakis A.D., Polyzos S.A., Makras P., Aubry-Rozier B., Kaouri S., Lamy O., 2017/06. Journal of bone and mineral research, 32 (6) pp. 1291-1296. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_346D492765E6]
 
Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.
Lamy O., Gonzalez-Rodriguez E., Aubry-Rozier B., 2017/06/01. The Journal of clinical endocrinology and metabolism, 102 (6) p. 2112. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3B4FB113AD58]
 
Bilan phosphocalcique perturbé dans le cadre d’une fragilité osseuse : des clés pour le praticien [Phosphocalcic anomalies and bone fragility keys for the general practitioner]
Aubry-Rozier B., Stoll D., Gonzalez-Rodriguez E., 2017/04/19. Revue medicale suisse, 13 (559) pp. 838-843. Peer-reviewed.
[Pmid][serval:BIB_D05D51F30E6F]
 
Dénosumab en routine clinique: précautions à prendre avant, pendant et après [Denosumab in clinical practice : beware before, during and after]
Lamy O., Gonzalez-Rodriguez E., Stoll D., Aubry-Rozier B., 2017/04/19. Revue medicale suisse, 13 (559) pp. 863-866. Peer-reviewed.
[Pmid][serval:BIB_F9A725F469AB]
 
Response to the Letter by Trovas.
Lamy O., Gonzalez-Rodriguez E., Aubry-Rozier B., 2017/04/01. The Journal of clinical endocrinology and metabolism, 102 (3) p. 1087. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4145CFFC9599]
 
Syndromes iatrogènes : les ostéopathies induites [Drugs induced osteopathies]
Aubry-Rozier B., 2017/03/08. Revue medicale suisse, 13 (553) pp. 549-553. Peer-reviewed.
[Pmid][serval:BIB_AAB5F4A8EA6B]
 
The lumbar spine age-related degenerative disease influences the BMD not the TBS: the Osteolaus cohort.
Padlina I., Gonzalez-Rodriguez E., Hans D., Metzger M., Stoll D., Aubry-Rozier B., Lamy O., 2017/03. Osteoporosis international, 28 (3) pp. 909-915. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5D8D66536236]
 
Impact of level of expertise versus the statistical tool on vertebral fracture assessment (VFA) readings in cohort studies.
Aubry-Rozier B., Fabreguet I., Iglesias K., Lamy O., Hans D., 2017/02. Osteoporosis international, 28 (2) pp. 523-527. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BA83D30612A0]
 
Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong.
Su Y., Leung J., Hans D., Aubry-Rozier B., Kwok T., 2017/01. Osteoporosis international, 28 (1) pp. 151-160. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B672F839C72C]
2016
 
Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report.
Lamy O., Gonzalez-Rodriguez E., Stoll D., Hans D., Aubry-Rozier B., 2016/10/12. The Journal of clinical endocrinology and metabolism, 102 (2) pp. 354-358. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1C2743310E67]
 
Osseous Sarcoidosis Revealed by a Pathologic Fracture and Successfully Treated With Methotrexate and Prednisone.
Ahmanna-Chakir F., Becce F., Aubry-Rozier B., 2016/10. Arthritis and Rheumatology (hoboken, N.j.), 68 (2) p. 472. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A8E812687DCA]
 
Severe spontaneous vertebral fractures after denosumab discontinuation: three case reports.
Aubry-Rozier B., Gonzalez-Rodriguez E., Stoll D., Lamy O., 2016/05. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 27 (5) pp. 1923-1925. Peer-reviewed.
[DOI][Pmid][serval:BIB_BE964606C7DC]
Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives.
Bregou Bourgeois A., Aubry-Rozier B., Bonafé L., Laurent-Applegate L., Pioletti D.P., Zambelli P.Y., 2016. Swiss medical weekly, 146 pp. w14322. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CFDB8F834667]
 
Potential blindness in children of patients with hereditary bone disease.
Kheir V., Munier F.L., Aubry-Rozier B., Schorderet D.F., 2016. Osteoporosis International : A Journal Established As Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa, 27 (2) pp. 841-844. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_400DAE403C5B]
2015
 
Nouveautés dans l'ostéogenèse imparfaite: de la recherche à la prise en charge multidisciplinaire [News in osteogenesis imperfecta: from research to clinical management]
Aubry-Rozier B., Unger S., Bregou A., Freymond Morisod M., Vaswani A., Scheider P., Bonafé L., 2015/03/18. Revue medicale suisse, 11 (466) pp. 657-658,660-662.
[Pmid][serval:BIB_EE63C48C6156]
 
AA amyloidosis treated with tocilizumab: case series and updated literature review.
Courties A., Grateau G., Philippe P., Flipo R.M., Astudillo L., Aubry-Rozier B., Fabreguet I., Fahd W., Fain O., Guggenbuhl P. et al., 2015. Amyloid, 22 (2) pp. 84-92. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_96A5E96BFB9C]
 
Anti-tumor necrosis factor drug survival in axial spondyloarthritis is independent of the classification criteria.
Zufferey P., Ghosn J., Becce F., Ciurea A., Aubry-Rozier B., Finckh A., So A.K., 2015. Rheumatology International, 35 (2) pp. 295-302. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F0557D852A7]
 
Reproducibility of Vertebral Fracture Assessment Readings From Dual-energy X-ray Absorptiometry in Both a Population-based and Clinical Cohort: Cohen's and Uniform Kappa.
Aubry-Rozier B., Chapurlat R., Duboeuf F., Iglesias K., Krieg M.A., Lamy O., Burnand B., Hans D., 2015. Journal of Clinical Densitometry, 18 (2) pp. 233-238. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A39DE0EB404F]
2014
 
Fractures atypiques du fémur: A propos de trois cas cliniques [Atypical fractures of the femur: apropos of 3 clinical cases].
Sanduloviciu M., Stoll D., Lamy O., Krieg M.A., Aubry-Rozier B., 2014. Praxis, 103 (16) pp. 939-944. Peer-reviewed.
[DOI][Pmid][serval:BIB_F8D8B41F8E71]
 
Morphometric Vertebral Assessments via the Use of Dual X-ray Absorptiometry for the Evaluation of Radiographic Damage in Ankylosing Spondylitis: A Pilot Study.
Aubry-Rozier B., Hans D., Krieg M.A., Lamy O., Dudler J., 2014. Journal of Clinical Densitometry, 17 (1) pp. 190-194. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2903BD455A8E]
Risks and benefits of percutaneous vertebroplasty or kyphoplasty in the management of osteoporotic vertebral fractures.
Lamy O., Uebelhart B., Aubry-Rozier B., 2014. Osteoporosis International, 25 (3) pp. 807-819.
[URN][DOI][WoS][Pmid][serval:BIB_92E471F35313]
 
Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: The Manitoba Bone Density Program.
Leslie W.D., Aubry-Rozier B., Lix L.M., Morin S.N., Majumdar S.R., Hans D., 2014. Bone, 67 pp. 10-14. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_EA7CAF4A6569]
 
Spine Bone Texture Assessed by Trabecular Bone Score (TBS) to Evaluate Bone Health in Thalassemia Major.
Baldini M., Ulivieri F.M., Forti S., Serafino S., Seghezzi S., Marcon A., Giarda F., Messina C., Cassinerio E., Aubry-Rozier B. et al., 2014. Calcified Tissue International, 95 (6) pp. 540-546. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7CC71B8BCFAF]
 
Spine trabecular bone score subsequent to bone mineral density improves fracture discrimination in women.
Krueger D., Fidler E., Libber J., Aubry-Rozier B., Hans D., Binkley N., 2014. Journal of Clinical Densitometry, 17 (1) pp. 60-65. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ED00DCAAE347]
 
Vertebral microarchitecture and fragility fracture in men: a TBS study.
Leib E., Winzenrieth R., Aubry-Rozier B., Hans D., 2014. Bone, 62 pp. 51-55. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F7DD0C8408D]
2013
Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?
Stoll D., Dudler J., Lamy O., Hans D., Krieg M.A., Aubry-Rozier B., 2013. Osteoporosis International, 24 (2) pp. 495-500.
[URN][DOI][WoS][Pmid][serval:BIB_A0F168F49098]
Changing the awareness of low vitamin D status in a rheumatology population: a pre/post-study.
Stoll D., Lamy O., Hans D., Zufferey P., So A., Krieg M.A., Aubry-Rozier B., 2013. Swiss Medical Weekly, 143 pp. w13891.
[URN][DOI][WoS][Pmid][serval:BIB_105DB72F0C45]
 
Clinical images: enchondromatosis (Ollier disease).
Cerny M., Rudiger H.A., Aubry-Rozier B., Dugert E., Becce F., 2013. Arthritis and Rheumatism, 65 (11) p. 2886.
[DOI][WoS][Pmid][serval:BIB_6E49149F6A76]
Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.
Krieg M.A., Aubry-Rozier B., Hans D., Leslie W.D., Manitoba Bone Density Program, 2013. Osteoporosis International, 24 (3) pp. 1073-1078.
[URN][DOI][WoS][Pmid][serval:BIB_EF08F3FD6714]
 
Les connectivites: progrès thérapeutiques et place de la biothérapie [Connective tissue diseases: news in therapy, role of biologics agents].
Aubry-Rozier B., Fabreguet I., 2013. Revue Médicale Suisse, 9 (377) pp. 556-560.
[Pmid][serval:BIB_6C98F6DAC5EF]
 
TBS (trabecular bone score) and diabetes-related fracture risk.
Leslie W.D., Aubry-Rozier B., Lamy O., Hans D., Manitoba Bone Density Program, 2013. Journal of Clinical Endocrinology and Metabolism, 98 (2) pp. 602-609.
[DOI][WoS][Pmid][serval:BIB_6FE8D0EBC9D3]
 
Two cases of Takayasu's arteritis occurring under anti-TNF therapy.
Mariani N., So A., Aubry-Rozier B., 2013. Joint, Bone, Spine, 80 (2) pp. 211-213.
[DOI][WoS][Pmid][serval:BIB_3F716B1CF304]
What was your fracture risk evaluated by FRAX(®) the day before your osteoporotic fracture?
Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D., 2013. Clinical Rheumatology, 32 (2) pp. 219-223.
[URN][DOI][WoS][Pmid][serval:BIB_2C5CE638F5F9]
2012
Voriconazole-induced periostitis.
Rossier C., Dunet V., Tissot F., Aubry-Rozier B., Marchetti O., Boubaker A., 2012/02. European journal of nuclear medicine and molecular imaging, 39 (2) pp. 375-376. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_686C121C4DA5]
 
A pilot study of the efficacy of IL1 blockade by anakinra in acute calcific periarthritis of the rotator cuff
Zufferey P., Faucherre M., Varisco P.A, Aubry B., Fabreguet I., So A.K., 2012. pp. S59 dans Annual Scientific Meeting of the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP), Arthritis and Rheumatism.
[WoS][serval:BIB_F55EC76C14BA]
 
Aspects thérapeutiques de la vitamine D: quels taux cibler avec quels traitements [Therapeutic goal of vitamin D: optimal serum level and dose requirements].
Lamy O., Aubry-Rozier B., Stoll D., 2012. Revue Médicale Suisse, 8 (360) pp. 2066-2071.
[Pmid][serval:BIB_7665E8865F83]
 
Beneficial effects of PTH on spine bone mineral density (BMD) and microarchitecture (TBS) parameters in postmenopausal women with osteoporosis. A 2-year study
Guenther Beatrice, Popp Albrecht, Stoll Delphine, Rosier Berengere Aubry, Perrelet Romain, Kasalicky Petr, Hans Didier, Lippuner Kurt, 2012. pp. S565 dans Osteoporosis and Bone Conference, Osteoporosis International.
[WoS][serval:BIB_A15F1751C9D1]
 
Beneficial effects of PTH on spine bone mineral density (BMD) and microarchitecture (TBS) parameters in postmenopausal women with osteoporosis: A 2-year study
Guenther Beatrice, Popp Albrecht W., Stoll Delphine, Rosier Berengere Aubry, Perrelet Romain, Hans Didier, Lippuner Kurt, 2012. pp. S332-S333 dans IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium, Osteoporosis International.
[WoS][serval:BIB_8AC8B55B1088]
 
Bone mineral density (BMD), micro-architecture estimation (TBS) and vertebral fracture assessment (VFA) extracted from a single DXA device in combination with clinical risk factors improve significantly the identification of women at high risk of fracture
Lamy O., Krieg M.A., Metzger M., Aubry-Rozier B., Stoll D., Hans D., 2012. pp. A23 dans Interdisziplinärer Fachkongress OSTEOLOGIE des Dachverbandes Osteologie (DVO), Osteologie.
[serval:BIB_259A52040B42]
 
Can the trabecular bone score (TBS) be considered as a major clinical risk factor (CRF) of osteoporotic fractures? A meta-like analysis
Hans D., Winzenrieth R., Aubry-Rozier B., Stoll D., Lamy O., Krieg M.A., 2012. pp. S151 dans ECTS 2012, 39th Annual Congress of the European Calcified Tissue Society, Bone.
[DOI][WoS][serval:BIB_7D9CF48DCE87]
 
Can the trabecular bone score be considered as a major clinical risk factor of osteoporotic fractures? A meta-like analysis.
Hans D., Winzenrieth R., Aubry-Rozier B., Stoll D., Lamy O., Krieg M.A., 2012. pp. A34 dans Interdisziplinärer Fachkongress OSTEOLOGIE des Dachverbandes Osteologie (DVO), Osteologie.
[serval:BIB_17B0BF9536B1]
 
Faut-il traiter l'osteoporose liee a la thalassemie majeure: deux cas cliniques [Should we treat thalassemia-induced osteoporosis: two case reports].
Lucini M., Stoll D., Aubry-Rozier B., Lamy O., 2012. Praxis, 101 (20) pp. 1325-1329.
[DOI][Pmid][serval:BIB_CE82E3999E85]
 
Fractures non traumatiques en fin de grossesse: s'agit-il toujours d'une ostéoporose? A propos de deux cas [Non-traumatic fractures at the end of a pregnancy: are there always of osteoporotic origin].
Monigel H., Stoll D., Aubry-Rozier B., Fetz G.L., Theumann N., Lamy O., 2012. Praxis, 101 (14) pp. 923-928.
[DOI][Pmid][serval:BIB_817F1094641F]
 
Fractures non traumatiques liées à la grossesse et à l'allaitement : s'agit-il toujours d'une ostéoporose? A propos de 2 cas
Monigel H., Stoll D., Aubry-Rozier B., Lamy O., 2012. dans 80. Jahrestagung der Schweizerischen Gesellschaft für Allgemeine Innere Medizin.
[serval:BIB_16BE606AF245]
 
FRAX in combination with microarchitecture estimation (TBS) showed the best vertebral fracture discrimination over stand-alone approaches: the OsteoLaus study
Lamy O., Krieg M. A., Stoll D., Aubry-Rozier B., Metzger M., Hans D., 2012. p. 665 dans IOF Regionals 2nd Middle East and Africa Osteoporosis Meeting / 6th Pan Arab Osteoporosis Congress (PAOC), Osteoporosis International.
[WoS][serval:BIB_9B698F85239B]
 
High prevalence of osteoporosis in Swiss women aged 60 and older: a 2-year pilot screening campaign.
Krieg M.A., Lamy O., Aubry-Rozier B., Stoll D., Hans D., Berthoud M., 2012. pp. S237 dans AGS 2012, Annual Scientific Meeting of the American Geriatrics Society, Journal of the American Geriatrics Society.
[WoS][serval:BIB_9B6A77853B95]
 
Nouveautés dans la prise en charge des fractures vertébrales ostéoporotiques: place de la vertébroplastie et de la kyphoplastie [Trends in the treatment of spinal osteoporic fractures: vertebroplasty and kyphoplasty].
Aubry-Rozier B., Krieg M.A., Lamy O., Tonetti J., Duff J., Schizas C., Theumann N., 2012. Revue Médicale Suisse, 8 (347) pp. 1417-1421.
[Pmid][serval:BIB_E0F19BC4FE3B]
 
Ostéomyélite sclérosante diffuse de la mandibule et SAPHO [Diffuse sclerosing osteomyelitis of the mandible and SAPHO].
Aubry-Rozier B., Basch A., Dudler J., 2012. Revue de Médecine Interne, 33 (6) pp. e34-e37.
[DOI][Pmid][serval:BIB_C42BA4FF0C4C]
Ostéoporose : les fractures non traumatiques de la personne âgées
Sanduloviciu M., Aubry-Rozier B., 2012. Info@gériatrie, 1 (3) pp. 6-12.
[URN][serval:BIB_5314D031C93C]
 
Place des antiarthrosiques symptomatiques d'action lente dans l'arthrose (sulfate de chondroïtine, glucosamine, acide hyaluronique) [Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)].
Aubry-Rozier B., 2012. Revue Médicale Suisse, 8 (332) pp. 571-576.
[Pmid][serval:BIB_9F54B7E7EAC2]
 
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
Diggle C.P., Parry D.A., Logan C.V., Laissue P., Rivera C., Restrepo C.M., Fonseca D.J., Morgan J.E., Allanore Y., Fontenay M. et al., 2012. Human Mutation, 33 (8) pp. 1175-1181.
[DOI][WoS][Pmid][serval:BIB_211F91A7C26D]
 
Spine trabecular bone score (TBS) subsequent to BMD improves vertebral and OP fracture discrimination in women
Krueger D., Fidler E., Libber J., Aubry-Rosier B., Hans D., Binkley N., 2012. pp. S336 dans IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium, Osteoporosis International.
[WoS][serval:BIB_C641A76668DD]
TBS en routine clinique: propositions d'utilisation - L'apport de la texture osseuse dans la prise en charge des ostéoporoses
Cormier C., Lamy O., Poriau S., Aubry-Rozier B., Bernard P., Bloch J.G., Cormier C., Stoll D., Dufour R., Héraud A. et al., 2012..
[URN][serval:BIB_5497AB852A54]
 
The OsteoLaus Cohort Study Bone mineral density, micro-architecture score and vertebral fracture assessment extracted from a single DXA device in combination with clinical risk factors improve significantly the identification of women at high risk of fracture
Lamy O., Krieg M.A., Stoll D., Aubry-Rozier B., Metzger M., Hans D., 2012. Osteologie, 21 (2) pp. 77-82.
[WoS][serval:BIB_03579CA9FC21]
 
What should be the intervention thresholds of trabecular bone score (TBS) when used as a major clinical risk factor (CRF) of osteoporotic fractures (OPS)? A meta-like analysis
Hans Didier, Winzenrieth Renaud, Aubry-Rozier Berengere, Stoll Delphine, Lamy Olivier, Krieg Marc-Antoine, 2012. pp. S569-S570 dans Osteoporosis and Bone Conference, Osteoporosis International.
[WoS][serval:BIB_0203F25F02A0]
 
What should be the intervention thresholds of trabecular bone score (TBS) when used as a major clinical risk factor (CRF) of osteoporotic fractures (OPs)? A meta-like analysis
Hans Didier, Winzenrieth Renaud, Aubry-Rozier Berengere, Stoll Delphine, Lamy Olivier, Krieg Marc-Antoine, 2012. pp. S301-S302 dans IOF-ECCEO European Congress on Osteoporosis and Osteoarthritis / 2nd IOF-ESCEO Pre-Clinical Symposium, Osteoporosis International.
[WoS][serval:BIB_48B81678A2A3]
2011
A single high dose of oral vitamin D3 is insufficient to correct a deficiency in a rheumatologic population
Stoll D., Lamy O., Krieg M.A., Hans D., Dudler J., So A., Aubry-Rozier B., 2011. p. 22 dans SBMS-SVGO/ASCO Joint Meeting 2011, Journal für Mineralstoffwechsel.
[URN][serval:BIB_33E5479E002C]
 
Adhésion thérapeutique et maladies chroniques: l'exemple de l'ostéoporose [Adherence and chronic disease: what's about osteoporosis].
Aubry-Rozier B., Lamy O., 2011. Revue Médicale Suisse, 7 (299) pp. 1316-1319.
[Pmid][serval:BIB_D1CCCECC2443]
 
Cervical myelopathy in hereditary multiple exostoses.
Burki V., So A., Aubry-Rozier B., 2011. Joint, Bone, Spine, 78 (4) pp. 412-414.
[DOI][WoS][Pmid][serval:BIB_3BB9DE876988]
 
Clinical Images: Polyostotic fibrous dysplasia.
Faucherre M., Pazár B., So A., Aubry-Rozier B., 2011. Arthritis and Rheumatism, 63 (9) p. 2616.
[DOI][WoS][Pmid][serval:BIB_9054C4EEE2FB]
 
Evaluation des facteurs de risque clinique et des données de la DXA (DMO: VFA; TBS) pour la prédiction du risque fracturaire : étude de cohorte OséoLaus
Lamy O., Krieg M.A., Metzger M., Aubry-Rozier B., Soll D., Hans D, 2011. dans 24e Congrès Français de Rhumatologie, Revue du Rhumatisme.
[serval:BIB_9E9B06D51915]
High prevalence of hypovitaminosis D in a Swiss rheumatology outpatient population.
Stoll D., Dudler J., Lamy O., Hans D., So A., Krieg M.A., Aubry-Rozier B., 2011. Swiss Medical Weekly, 141 (w13196) pp. 1-5.
[URN][DOI][WoS][Pmid][serval:BIB_07E57C46D35E]
 
How High Dose(s) of Oral Vitamin D3 Can Correct Insufficiency in a Non Supplemented Rheumatologic Population ?
Lamy O., Hans D., Krieg M.A., Dudler J., Aubry-Rozier B., Stoll D., 2011. dans ASBMR 2011, Annual Meeting of the American Society for Bone and Mineral Research.
[serval:BIB_C061B97EFF6B]
IVA in addition to BMD can change the osteoporosis management in 25% of clinical routine patients
Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D., 2011. p. 21 dans SBMS-SVGO/ASCO Joint Meeting 2011, Journal für Mineralstoffwechsel.
[URN][serval:BIB_4E446F33B4BD]
 
La cohorte OstéoLaus: évaluation des outils de routine clinique pour la prédiction de la fracture ostéoporotique [OsteoLaus: prediction of osteoporotic fractures by clinical risk factors and DXA, IVA and TBS].
Lamy O., Metzger M., Krieg M.A., Aubry-Rozier B., Stoll D., Hans D., 2011. Revue Médicale Suisse, 7 (315) pp. 2130, 2132-2134, 2136.
[Pmid][serval:BIB_42EEFE363F54]
 
Ossification du ligament commun cervical postérieur : coexistence de spondylarthrite et d'une hyperostose idiopathique diffuse du squelette
Fabreguet I., Aubry-Rozier B., Richarme D., Varisco P.A., Zufferey P., So A.K., 2011. pp. A183 dans 24e Congrès Français de Rhumatologie, Revue du Rhumatisme.
[serval:BIB_3AB1643E869B]
 
Rhumatologie. Anti-TNF alpha: quels risques infectieux? Recommandations pratiques [Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations].
Faucherre M., Pazar B., So A., Aubry-Rozier B., 2011. Revue Médicale Suisse, 7 (277) pp. 75-6, 78-9.
[Pmid][serval:BIB_D6470C11F20E]
 
Syndrome des anti-synthétases et tacrolimus: efficacité et tolérance, à propos de 2 cas
Aubry-Rozier B., Zufferey P., Fabreguet I., So A.K., 2011. pp. A188-189 dans 24e Congrès Français de Rhumatologie, Revue du Rhumatisme.
[serval:BIB_CDC0B576F0B3]
 
TBS discrimine les femmes avec ostéoporose des femmes non ostéoporosiques indépendamment de la DMO, de l'âge et de l'IMC : étude de la cohorte Oséo-Mobile Vaud
Krieg M.A., Lamy O., Aubry-Rozier B., Stoll D., Krieg C., Berthoud M., Hans D., 2011. dans 24e Congrès Français de Rhumatologie, Revue du Rhumatisme.
[serval:BIB_2A52C59809BD]
 
TBS discrimine les femmes avec ostéoporose fracturaire des femmes non ostéoporotiques indépendamment de la DMO, de l'âge et de l'IMC : Etude de la cohorte Ostéo-Mobile Vaud
Krieg M.A., Lamy O., Aubry-Rozier B., Stoll D., Krieg C., Berthoud M., Hans D., 2011. pp. A66-A67 dans 24e Congrès Français de Rhumatologie, Revue du Rhumatisme.
[serval:BIB_7BDC7E7292A4]
 
Terminal phalangeal osteosclerosis and rheumatoid arthritis.
Currat M., Aubry-Rozier B., Dudler J., 2011. Canadian Medical Association Journal = Journal de L'association Médicale Canadienne, 183 (7) pp. E428.
[DOI][WoS][Pmid][serval:BIB_8D17F4A735B3]
 
Tocilizumab in axial spondylarthripathies : report of 18 cases
Dudler J., Aubry-Rozier B., 2011. dans EULAR 2011, European League Against Rheumatism Congress 2011.
[serval:BIB_5C1D532F841C]
 
Treatment of osteitis pubis with on single iv injection of Ibandronate: report of two cases
Zufferey P., Aubry-Rozier B., 2011. pp. 164-165 dans ECCEO11-IOF, European Congress on Osteoporosis and Osteoarthritis, Osteoporosis International. Peer-reviewed.
[WoS][serval:BIB_E30DFD250600]
 
Treatment of symphysitis pubis with one unique iv injection of Ibandronate: report of two cases
Zufferey P., So A.K., Aubry-Rozier B., 2011. pp. 5S dans Annual meeting of the Swiss Society of Rheumatology, Swiss Medical Weekly. Peer-reviewed.
[serval:BIB_298148E29533]
2010
 
A single high dose of oral Vitamin D3 is not enough to correct insufficiency and deficiency in a rheumatologic population
Stoll D., Lamy O., Krieg M.A., Hans D., Dudler J., So A., Aubry-Rozier B., 2010. dans ASBMR 2010, 30th Annual Meeting of the American Society for Bone and Mineral Research, Journal of Bone and Mineral Research. Peer-reviewed.
[serval:BIB_7B4CED1BC604]
 
Déficit en vitamine D et fractures
Basch A., Aubry-Rozier B., Krieg M.A., Lamy O., 2010. pp. 45S dans 78. Jahresversammlung der Schweizerischen Gesellschaft für Innere Medizin, Swiss Medical Forum = Forum Médical Suisse.
[serval:BIB_E855AA57B00A]
 
Facteurs de risque fracturaire, nouveaux traitements: comment evolue la prise en charge de l'ostéoporose de la personne agée [Fracture risk, new treatments: how does the management of the osteoporosis of elderly change?]
Aubry-Rozier B., Lamy O., 2010. Revue Médicale Suisse, 6 (240) pp. 569-574.
[Pmid][serval:BIB_7DA1C4EF56AB]
 
IVA in addition to BMD can change the osteoporosis management in 25% of clinical routine patients.
Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D., 2010. dans ASBMR 2010, 30th Annual Meeting of the American Society for Bone and Mineral Research, Journal of Bone and Mineral Research. Peer-reviewed.
[serval:BIB_3C231B5E5B66]
 
Kyste synovial de l'épaule traité par aspiration et infiltration sous échographie : rapport de 3 cas avec pathologies différentes
Pazar B., Faucherre M., Buss G., Rappoport G., Revaz S., Aubry-Rozier B., So A., Zufferey P., 2010. dans SFR 2010, 23e Congrès de la Société Française de Rhumatologie.
[serval:BIB_222FAD424E26]
 
Messages clefs du "30th American Society for Bone and Mineral Research"
Aubry-Rozier B., Lamy O., 2010. pp. 886-887 dans 30th American Society for Bone and Mineral Research, Swiss Medical Forum = Forum Médical Suisse.
[serval:BIB_CB43265AE2C0]
 
Prophytaxie de l'ostéoporose cortisonique: qui, quand et quoi [Prevention of cortisone-induced osteoporosis: who, when and what?]
Aubry-Rozier B., Lamy O., Dudler J., 2010. Revue Médicale Suisse, 6 (235) pp. 307-313.
[Pmid][serval:BIB_14DB30821BE6]
2009
 
Déficit en vitamine D et fractures en Suisse : Lu.76
Basch A., Krieg M.A., Lamy O., Aubry-Rozier B., 2009. pp. 1073-1074 dans SFR 2009, 22e Congrès Français de Rhumatologie, Revue du Rhumatisme.
[serval:BIB_51BEF7ED3523]
 
Osteoporotic fractures : A new collaboration with surgeons : P17
Aubry-Rozier B., Krieg M.A., Moushine E., Lamy O., 2009. pp. 6-7 dans Annual meeting of the Swiss Society of Rheumatology (SGR), Symposium Health Professionals in Rheumatology combined with the 6th Conference on Sex Hormones, Pregnancy and Rheumatic Diseases, Swiss Medical Weeky. Peer-reviewed.
[serval:BIB_9613D36ACA4F]
 
Quel était votre FRAX? la veille de votre fracture? : O.01
Basch A., Dudler J., Krieg M.A., Lamy O., Moushine E., Aubry-Rozier B., 2009. p. 982 dans SFR 2009, 22e Congrès de la Société Française de Rhumatologie, Revue du Rhumatisme.
[serval:BIB_D5D6A84B0880]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University